Increased plasma levels of endothelin-1 and urotensin-II in patients with coronary heart disease

Heart and Vessels

Volumn 25, Issue 2, 2010, Pages 138-143

  Chai, San Bao ^a   Li, Xue Min ^b   Pang, Yong Zheng ^c   Qi, Yong Fen ^c   Tang, Chao Shu ^c  

^a Huaishuling Branch of Beijing Fengtai Hospital of Integrated Traditional Chinese and Western Medicine   (China)

^b PEKING UNIVERSITY   (China)

^c PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Coronary heart disease; Endothelin 1; Percutaneous transluminal coronary angioplasty; Urotensin II

Indexed keywords

ENDOTHELIN 1; UROTENSIN II;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATIONAL STUDY; EARLY INTERVENTION; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; PATIENT ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RADIOIMMUNOASSAY; STENT; THERAPY EFFECT;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY DISEASE; ENDOTHELIN-1; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; STENTS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION; UROTENSINS;

EID: 77950945969     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-009-1178-6     Document Type: Article

References (27)

1. M. Yanagisawa H. Kurihara S. Kimura Y. Tomobe M. Kobayashi T. Mitsui Y. Yazaki K. Goto T. Masaki 1988 A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 411 415 10.1038/332411a0 1:CAS:528:DyaL1cXlsVaks78%3D 2451132 (Pubitemid 18090241)
2. A.J. Sutherland M.I. Nataatmadja P.J. Walker L. Cutte R.B. Garlick M.J. West 2006 Vascular remodeling in the internal mammary artery graft and association with in situ endothelin-1 and receptor expression Circulation 113 1180 1188 10.1161/CIRCULATIONAHA.105.582890 1:CAS:528:DC%2BD28XhvVektrc%3D 16505174
3. H.A. Bern D. Pearson B.A. Larson R.S. Nishioka 1985 Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes Recent Prog Horm Res 41 533 552 1:CAS:528:DyaL2MXlslGltLY%3D 2864726
4. S.A. Douglas E.H. Ohlstein 2000 Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease Trends Cardiovasc Med 10 229 237 10.1016/S1050-1738(00)00069-4 1:CAS:528:DC%2BD3MXitF2ktrw%3D 11282300 (Pubitemid 32229878)
5. J.J. Maguire R.E. Kuc K.E. Wiley M.J. Kleinz A.P. Davenport 2004 Cellular distribution of immunoreactive urotensin-II in human tissue with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries Peptides 25 1767 1774 10.1016/j.peptides.2004.01.028 1:CAS:528:DC%2BD2cXotlWgtLw%3D 15476944 (Pubitemid 39346219)
6. N. Bousette L. Patel S.A. Douglas E.H. Ohlstein A. Giaid 2004 Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta Atherosclerosis 176 117 123 10.1016/j. atherosclerosis.2004.03.023 1:CAS:528:DC%2BD2cXmslersrY%3D 15306183 (Pubitemid 39078653)
7. H. Lapp G. Boerrigter L.C. Costello-Boerrigter K. Jaekel T. Scheffold I. Krakau M. Schramm H. Guelker J.P. Stasch 2004 Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy Int J Cardiol 94 93 97 10.1016/j.ijcard.2003.05.008 14996481 (Pubitemid 38314694)
8. L.L. Ng I. Loke R.J. O'Brien I.B. Squire J.E. Davies 2002 Plasma urotensin in human systolic heart failure Circulation 106 2877 2880 10.1161/01.CIR.0000044388.19119.02 1:CAS:528:DC%2BD38XovVelt7c%3D 12460864 (Pubitemid 35424734)
9. A.M. Richards M.G. Nicholls J.G. Lainchbury 2002 Plasma urotensin II in heart failure Lancet 360 545 546 10.1016/S0140-6736(02)09709-X 1:CAS:528:DC%2BD38XmtlelsrY%3D 12241661 (Pubitemid 35232110)
10. F.D. Russell D. Meyers A.J. Galbraith 2003 Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure Am J Physiol Heart Circ Physiol 285 H1576 1581 1:CAS:528:DC%2BD3sXosVKjt7c%3D 12791592
11. M. Heringlake T. Kox O. Uzun B. Will L. Bahlmann S. Klaus S. Eleftheriadis F.P. Armbruster N. Franz E. Kraatz 2004 The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease Regul Pept 121 129 136 10.1016/j.regpep.2004.04.012 1:CAS:528:DC%2BD2cXlsl2jsLw%3D 15256283 (Pubitemid 38901071)
12. J. Hongfang C. Bailin Z. Bin Z.H. Chunyu L. Xinmin Z.H. Weijin S.H. Ying T. Chaoshu D. Junbao 2006 Effects of hydrogen sulfide on hypoxic pulmonary vascular structural remodeling Life Sci 78 1299 1309 10.1016/j.lfs.2005.07.009 16257422 (Pubitemid 43199950)
13. G.S. Sainani V.G. Maru A.P. Mehra 2005 Role of endothelin-1 in genesis of coronary artery disease Indian Heart J 57 121 127 16013351
14. A. Lerman B.S. Edwards J.W. Hallett D.M. Heublein S.M. Sandberg J. J. Burnett 1991 Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis N Engl J Med 325 997 1001 1:STN:280:DyaK3MzmtVWhug%3D%3D 1886637
15. A.M. Malek J. Zhang J. Jiang S.L. Alper S. Izumo 1999 Endothelin-1 gene suppression by shear stress: pharmacological evaluation of the role of tyrosine kinase, intracellular calcium, cytoskeleton, and mechanosensitive channels J Mol Cell Cardiol 31 387 399 10.1006/jmcc.1998.0873 1:CAS:528:DyaK1MXhs1Wrsbo%3D 10093051 (Pubitemid 29089887)
16. T. Ziegler K. Bouzourene V.J. Harrison H.R. Brunner D. Hayoz 1998 Influence of oscillatory and unidirectional flow environments on the expression of endothelin and nitric oxide synthase in cultured endothelial cells Arterioscler Thromb Vasc Biol 18 686 692 1:CAS:528:DyaK1cXjsF2rs7c%3D 9598825
17. J. Ketonen E. Mervaala 2008 Effect of dietary sodium on reactive oxygen species formation and endothelial dysfunction in low-density lipoprotein receptor-deficient mice on high-fat diet Heart Vessels 23 420 429 10.1007/s00380-008-1066-5 19037590
18. G. Niccoli G.A. Lanza S. Shaw E. Romagnoli E. Romagnoli D. Gioia F. Burzotta C. Trani M.A. Mazzari R. Mongiardo M. DeVita A.G. Rebuzzi T.F. Lüscher F. Crea 2006 Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization Eur Heart J 27 1793 1798 10.1093/eurheartj/ehl119 1:CAS:528:DC%2BD28Xpt1yltL0%3D 16829540 (Pubitemid 44297383)
19. E. Rakowski G.S. Hassan D. Dhanak E.H. Ohlstein S.A. Douglas A. Giaid 2005 A role for urotensin II in restenosis following balloon angioplasty: use of a selective UT receptor blocker J Moll Cell Cardiol 39 785 791 10.1016/j.yjmcc.2005.07.002 1:CAS:528:DC%2BD2MXhtFCjsLbI (Pubitemid 41464415)
20. M. Birker-Robaczewska C. Boukhadra R. Studer C. Mueller C. Binkert O. Nayler 2003 The expression of urotensin II receptor (U2R) is up-regulated by interferon-gamma J Recept Signal Transduct Res 23 289 305 10.1081/RRS-120026972 1:CAS:528:DC%2BD2cXptlyhsA%3D%3D 14753294 (Pubitemid 38018398)
21. M.C. Chen C.J. Chen C.H. Yang C.J. Wu C.Y. Fang Y.K. Hsieh H.W. Chang 2007 Interleukin-18: a strong predictor of the extent of coronary artery disease in patients with unstable angina Heart Vessels 22 371 375 10.1007/s00380-007- 0991-z 18043993 (Pubitemid 350213857)
22. N. Shirai T. Naruko M. Ohsawa Y. Ikura Y. Sugama M. Hirayama C. Kitabayashi S. Ehara T. Inoue A. Itoh K. Haze K. Tanzawa M. Yoshiyama J. Yoshikawa M. Ueda 2006 Expression of endothelin-converting enzyme, endothelin-1 and endothelin receptors at the site of percutaneous coronary intervention in humans J Hypertens 24 711 721 10.1097/01.hjh.0000217854.97369.8c 1:CAS:528:DC%2BD28Xitlakur4%3D 16531800
23. H.K. Yip C.J. Wu H.W. Chang C.H. Yang T.H. Yu Y.H. Chen C.L. Hang 2005 Prognostic value of circulating levels of endothelin-1 in patients after acute myocardial infarction undergoing primary coronary angioplasty Chest 127 1491 1497 10.1378/chest.127.5.1491 1:CAS:528:DC%2BD2MXkvFyhsL8%3D 15888819 (Pubitemid 46218771)
24. M.R. MacLean D. Alexander A. Stirrat M. Gallagher S.A. Douglas E.H. Ohlstein 2000 Contractile response to human urotensin II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat Br J Pharmacol 130 201 204 10.1038/sj.bjp.0703314 1:CAS:528: DC%2BD3cXjsl2mtLg%3D 10807654
25. G. Thanassoulis T. Huyhn A. Giaid 2004 Urotensin II and cardiovascular disease Peptide 25 1789 1794 10.1016/j.peptides.2004.05.027 1:CAS:528: DC%2BD2cXotlWgtLs%3D (Pubitemid 39346222)
26. N.S. Lamarre R.J. Tallarida 2008 A quantitative study to assess synergistic interaction between urotensin II and angiotensin II Eur J Pharmacol 586 350 351 10.1016/j.ejphar.2008.02.071 1:CAS:528:DC%2BD1cXmsVGmtbk%3D 18371948
27. G. Ahlborg A. Shemyakin F. BÖhm A. Gonon J. Pernow 2007 Dual endothelin receptor blockade acutely improves insulin sensitivity in obese patients with insulin resistance and coronary artery disease Diabetes Care 30 591 596 10.2337/dc06-1978 1:CAS:528:DC%2BD2sXjs1GrtLY%3D 17327326 (Pubitemid 46354339)